?? ?? Happy Employee Appreciation Day! We want to give a BIG shout out and THANK YOU to the Previse team for everything you do to advance the health and outcomes of the patients we serve and your unwavering support for the healthcare professionals who care for them. We couldn't do it without you! ? ? #teamwork #gratitude #appreciation #thankful
Previse
生物技术研究
Previse is on a mission to save lives through the prediction and earlier detection of cancer.
关于我们
Previse is on a mission to save lives through the earlier detection and prevention of cancer, starting with esophageal cancer. They are actively working to get patients and healthcare providers the answers they need sooner by understanding and unlocking the power of biomarkers on cancer development and severity. Previse’s technology was made possible by grants from the National Institutes of Health (“NIH”) and developed after decades of research by the GI Early Detection Biomarker Lab at the Johns Hopkins University School of Medicine. An esophageal cancer diagnosis is something that nobody wants to hear. Today, this cancer takes 16,000 lives in the United States each year. The primary reason - the current detection method, upper endoscopy, is both invasive and expensive, so it's often not used until symptoms arise. In over 75% of cases, this is after the cancer has already spread and treatment options are limited, leading to esophageal cancer being the 3rd most lethal cancer in the United States (behind only pancreatic and lung cancer). Previse's early-detection system combines a simple routine test given as part of routine care with our patented DNA biomarkers that accurately test for disease. Our system is convenient, inexpensive, and accurate, so it can be given to those at risk before cancer symptoms, empowering patients to know earlier, receive necessary treatments, and live a healthier, longer life.
- 网站
-
https://www.previsedx.com/
Previse的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Baltimore
- 类型
- 私人持股
- 创立
- 2018
- 领域
- diagnostics、medical device、medicine、early detection和medtech
地点
-
主要
获取路线
US，Baltimore
Previse员工
动态
-
A new article in Healio highlights a recently published study led by Previse founder Stephen J. Meltzer, demonstrating the potential of a methylated DNA biomarker panel for detecting Barrett’s esophagus and esophageal cancer. At Previse, we currently offer Esopredict, a DNA methylation-based test for risk stratification in Barrett’s esophagus, and are advancing tools—including the one highlighted in this article—to increase access and improve patient outcomes. https://lnkd.in/eJ2fPsvP
-
?? ?? Today’s announcement marks yet another significant milestone for patients living with pre-cancerous Barrett’s esophagus and their talented GI specialists who desire faster, more precise risk stratification answers to guide long term BE care and treatment. ?? Congratulations to the entire Previse team and study authors on this important peer-reviewed clinical validation publication! https://lnkd.in/gpJZ7hWu #innovation #precisiondiagnostics #moleculardiagnostics #gi #gastroenterology #barrettsesophagus #riskstratification #betterhealthcare
-
Previse is growing! If you’re passionate about providing innovative solutions to GI providers to improve patient care, click on the link below. https://lnkd.in/eegBK_5X
-
Happy New Year from the Previse team! “The new year stands before us, like a chapter in a book, waiting to be written.” —Melody Beattie We sincerely hope your 2025 will be a year filled with opportunities, adventures, and amazing memories to make with friends, colleagues, and loved ones alike.
-
-
We are thankful for this celebratory season which offers us a time of reflection on the year nearing its close and the hope and promise of a new year ahead. Everyone at Previse hopes Kwanzaa brings our Linked In community the time to enjoy the blessings of family, community and togetherness. Happy Kwanzaa!
-
?? In this season of hustle and bustle, of family gatherings, festivities, and spreading of good cheer...everyone at Previse would like to take a moment to wish all of you a very Merry Christmas and Happy New Year! Here's looking to the new year ahead and wishing you all the best!
-
Congratulations to Previse Scientific Advisor Dr Stephen Baylin and his colleagues Drs Andrew Feinberg and Peter Jones for receiving the prestigious Harvey Prize in recognition of their pioneering research in epigenetics!
Congratulations to Johns Hopkins Medicine scientists Stephen Baylin and Andrew Feinberg for receiving the prestigious Harvey Prize in Science and Technology! Their groundbreaking research in epigenetics has revolutionized our understanding of cancer and gene regulation. Join us in celebrating their incredible achievements and contributions to science!?https://lnkd.in/erKEiXKf
-
-
Wishing you peace, prosperity, and plenty of turkey, mashed potatoes, and pumpkin pie! Happy Thanksgiving from the Previse team! We are truly grateful for all of you! #grateful #happy #thanksgiving #friends #family #makingmemories
-